» Articles » PMID: 36164393

MKK4 Knockdown Plays a Protective Role in Hemorrhagic Shock-Induced Liver Injury Through the JNK Pathway

Overview
Publisher Wiley
Date 2022 Sep 27
PMID 36164393
Authors
Affiliations
Soon will be listed here.
Abstract

Hemorrhagic shock (HS) triggers tissue hypoxia and organ failure during severe blood loss, and the liver is sensitive to HS. Mitogen-activated protein kinase kinase 4 (MKK4) activates the c-Jun NH2-terminal kinase (JNK) pathway, and its expression is upregulated in the serum of HS patients and mouse livers at 1 h post-HS. However, the function of MKK4 in HS-induced liver injury is unclear. The role of MKK4 was investigated using rat models of HS. Before HS, lentivirus harboring shRNA against MKK4 was injected into rats via the tail vein to knock down MKK4 expression. HS was induced by bloodletting via intubation of the femoral artery followed by resuscitation. The results showed that MKK4 knockdown reduced HS-induced apoptosis in the liver by decreasing Bax expression and the cleavage of caspase 3 and promoting Bcl-2 expression. Moreover, the generation of intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) in the liver was promoted, while superoxide dismutase (SOD) activity was inhibited by HS. However, the effect of HS on oxidative stress was abrogated by MKK4 knockdown. Furthermore, MKK4 knockdown restored MMP and complex I and complex III activities and promoted ATP production, suggesting that HS-induced mitochondrial dysfunction in the liver was ameliorated by MKK4 knockdown. The inhibitory effect of MKK4 knockdown on the phosphorylation and activation of the JNK/c-Jun pathway was confirmed. Overall, MKK4 knockdown may suppress oxidative stress and subsequent apoptosis and improve mitochondrial function in the liver upon HS by inhibiting the JNK pathway. The MKK4/JNK axis was shown to be a therapeutic target for HS-induced liver injury in this study.

Citing Articles

Systemic mechanism of Panax noteginseng saponins in antiaging based on network pharmacology combined with experimental validation.

Zhao Y, Yang L, Que S, An L, Teeti A, Xiao S Ibrain. 2024; 10(4):519-535.

PMID: 39691419 PMC: 11649391. DOI: 10.1002/ibra.12165.


Involvement of CD44 and MAPK14-mediated ferroptosis in hemorrhagic shock.

Ye H, He S, Du Y, Wang Y, Hu Y, Zhao C Apoptosis. 2023; 29(1-2):154-168.

PMID: 37751106 DOI: 10.1007/s10495-023-01894-6.


MKK4 Knockdown Plays a Protective Role in Hemorrhagic Shock-Induced Liver Injury through the JNK Pathway.

Yao H, Gao Y, Han J, Wang Y, Cai J, Rui Y Oxid Med Cell Longev. 2022; 2022:5074153.

PMID: 36164393 PMC: 9509254. DOI: 10.1155/2022/5074153.

References
1.
Bogomolova A, Shavva V, Nikitin A, Nekrasova E, Dizhe E, Larionova E . Hypoxia as a Factor Involved in the Regulation of the apoA-1, ABCA1, and Complement C3 Gene Expression in Human Macrophages. Biochemistry (Mosc). 2019; 84(5):529-539. DOI: 10.1134/S0006297919050079. View

2.
Ouyang X, Han S, Zhang J, Dioletis E, Nemeth B, Pacher P . Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis. Cell Metab. 2018; 27(2):339-350.e3. PMC: 5806149. DOI: 10.1016/j.cmet.2018.01.007. View

3.
Preston S, Doerflinger M, Scott H, Allison C, Horton M, Cooney J . The role of MKK4 in T-cell development and immunity to viral infections. Immunol Cell Biol. 2020; 99(4):428-435. PMC: 8247422. DOI: 10.1111/imcb.12426. View

4.
Sims C, Baur J . The grapes and wrath: using resveratrol to treat the pathophysiology of hemorrhagic shock. Ann N Y Acad Sci. 2017; 1403(1):70-81. DOI: 10.1111/nyas.13444. View

5.
Ashok Kumar D, Palanichamy V, Roopan S . Green synthesis of silver nanoparticles using Alternanthera dentata leaf extract at room temperature and their antimicrobial activity. Spectrochim Acta A Mol Biomol Spectrosc. 2014; 127:168-71. DOI: 10.1016/j.saa.2014.02.058. View